superDimension, First Device to Enable Minimally-Invasive Access to Distant Areas of Lungs

Sept. 5, 2007 – The first device to allow physicians to access smaller, harder-to-reach lung lesions has received 510(k) clearance from the Food and Drug Administration (FDA). The inReach^TM System, developed by Minneapolis-based superDimension, provides electromagnetic navigation and guidance to distant regions of the lungs in a minimally-invasive manner, enabling doctors to diagnose lung cancer at earlier stages and potentially provide treatment sooner... Read superDimension's Press Release -